All In MedTech

FDA Clearance Tracker · P010059-S006

FortiEYE CAPSULAR TENSION RINGS, TYPES 14, 14A AND 14C

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 26, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 26, 2017

Approved

Time to decision

177 days

Received Aug 2, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010059-S006
Device name
FortiEYE CAPSULAR TENSION RINGS, TYPES 14, 14A AND 14C
Applicant
Morcher GmbH
Applicant location
Stuttgart
Received
Aug 2, 2016
Decided
Jan 26, 2017
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P010059

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MRJ

FDA's approval statement

As written in FDA's record.

Approval for new private labeling for an alternative distributor.

Source documents

Other decisions for Morcher GmbH

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.